The size of the global minimally invasive surgery market is estimated to value USD 27.34 billion by 2028 from USD 17.05 billion in 2023, growing at a CAGR of 9.9% from 2023 to 2028.
Minimally invasive surgery is when only small incisions and stitches are made on the body during surgery. The process aims at creating a less painful surgical operation that requires less time to heal and helps the patient fasten the recovery procedure. Minimally invasive surgery like laparoscopy and robotic surgery uses small tubes and surgical equipment to send cameras into the body and the tissue that needs repairs and perform surgery without causing much damage. This type of surgery is encouraged due to its usefulness in reducing surgery risks.
Impact of COVID-19 on the global minimally invasive surgery market:
The COVID-19 pandemic brought forth a situation of panic worldwide. Many businesses were closed, and the pandemic disrupted the manufacturing and supply chains due to the government's stringent lockdowns and quarantine programs. As a result, the world faced a crisis in products and services. The healthcare sector was one of the most heavily affected segments during the pandemic. The lack of adequate resources and hospital professionals led to the denial of service for many patients. COVID-19 had a negative impact on the global minimally invasive surgery market. This negative impact was because of a rapid influx of covid-19 patients at healthcare centers. So many hospitals shifted their attention entirely to covid-19 care, diverting as many staff as possible toward the patients. This led to the postponement of non-urgent surgical procedures, and robotic and laparoscopy surgeries, along with the minimally invasive diagnosis, were all put on hold. Additionally, due to the emergence of the pandemic, the public became skeptical about opting for elective surgery, and the demand for minimally invasive surgery fell considerably. These factors made the market for minimally invasive surgery decline thoroughly during the pandemic.
Factors such as the growing prevalence of chronic diseases like kidney, heart, respiratory, and others are majorly propelling the growth of the minimally invasive surgery market. Furthermore, advancements in surgical technology, and an aging population who are prone to illnesses that require surgery, are further anticipated to boost the growth rate of the minimally invasive surgery market. In addition, the market's overall expansion is also being accelerated by consumer healthcare spending, investment, and the expanding use of minimally invasive treatments as an elective choice.
The increasing use of surgical procedures, such as aesthetic surgical treatments, laparoscopic treatment, and robotic surgery globally, as well as several advantages over current systems, such as a decreased risk of infection, a reduced need for painkillers, a quicker recovery period, less physical strain on the body, and less blood loss, are also propelling the significant growth of the global minimally invasive surgery market.
The rise in the number of surgical procedures and the demand for laparoscopic surgery drive the growth of the minimally invasive surgery market.
Around 40 to 50 million surgical procedures are performed annually in the USA, and 20 million in Europe, for a startling total of 310 million worldwide. According to estimates, 1-4% of these patients will pass away, up to 15% will experience substantial postoperative morbidity, and 5–15% will require re-admission within 30 days. Major surgery is comparable to the top causes of death from cardiovascular disease and stroke, cancer, and accident, with an annual mortality rate of about 8 million patients worldwide, leading the market to grow.
Furthermore, many healthcare centers use laparoscopy surgical procedures to fuel the market's growth. For instance, currently, 94% of bariatric surgeries, 83.7% of antireflux surgeries, 79.2% of appendectomies, 77.1% of cholecystectomy procedures, 52.4% of colectomies, 28.1% of ventral hernia repairs, and 18.3% of rectal resections are performed laparoscopically.
The high cost of treatment associated with minimally invasive surgical procedures and the lack of skilled professionals in the field is expected to hamper the growth of the minimally invasive surgery market.
This report on the global minimally invasive surgery market includes the following segmentation.
Global Minimally Invasive Surgery Market - By Surgery Type:
Based on the surgery type, the laparoscopic surgery segment dominated the minimally invasive surgery market in 2022 and is expected to continue the dominating trend throughout the forecast period. The segment's growth is due to the increased demand for laparoscopic surgery and the innovations in the technology used during laparoscopic surgery.
However, the robotic surgery segment is also expected to witness growth due to increased cases of robotics-assisted surgeries.
Global Minimally Invasive Surgery Market - By Condition:
Based on the condition, the gynecological conditions segment is expected to dominate the minimally invasive surgery market during the forecast period owing to the rise in the female population and the stringent government regulations to develop the segment. However, during the forecast period, the spinal conditions segment is expected to continue contributing the most to the market due to the rise in axial spondyloarthritis cases and the growth in technology.
Global Minimally Invasive Surgery Market - By End-User:
Based on the end-user, the hospitals and clinics segment is anticipated to hold a significant share of the global minimally invasive surgery market during the forecast period. This domination results from the hospitals receiving an increasing number of patients, the public's trust in them, and the presence of high-quality technology in hospitals. However, the ambulatory surgical centers segment is also expected to grow due to the demand for elective surgical procedures.
Global Minimally Invasive Surgery Market - By Region:
The market for minimally invasive surgery worldwide was dominated by North America in 2022 and is predicted to continue doing so during the forecast period due to the region's rising prevalence of chronic diseases, the presence of important players, and the expansion of the healthcare industry, and technological advancements in diagnostic instruments in countries like the U.S., and Canada.
Due to increased surgical procedures, a rise in demand for minimally invasive surgery, improvements in the healthcare infrastructure, and technological advancements in minimally invasive surgical instruments in countries like China, Japan, and India, Asia-Pacific is predicted to experience the highest CAGR during the forecast period.
In 2020, Europe held a significant market share for minimally invasive surgery worldwide. Due to a rise in the number of older people in the area, the trend is expected to continue over the projection period. According to Eurostat, one-fifth of the people in the European Union (E.U.) were 65 years of age or older in 2017.
TOP COMPANIES IN THIS MARKET:
Circle Health Ltd., Manipal Health Enterprises Pvt. Ltd., Apollo Hospitals Enterprise Ltd., Bedfordshire Hospitals, King Fahd Medical City, Mount Elizabeth Hospital, Singapore General Hospital Ltd., Stanford Healthcare, The General Hospital Corporation, and The Johns Hopkins Hospital are some of the noteworthy companies in the global minimally invasive surgery market and profiled in this report.
The global minimally invasive surgery market size was valued at USD 14.12 billion in 2021.
The Europe minimally invasive surgery market is estimated to grow at a CAGR of 9.05% from 2022 to 2027.
Based on the surgery type, the laparoscopic surgery segment had the major share of the global minimally invasive surgery market in 2021.
Geographically, the APAC region is predicted to be growing the fastest in the global market during the forecast period.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com